A clinical study involving Type 2 Diabetes patients conducted at Heidelberg University in Germany may lead the way in seeing Continuous Glucose Monitoring (CGM) hopefully entering the market as a cost effective way of monitoring blood sugars on par with conventional finger picking blood sugar monitors. While we maybe a while away from a cure for diabetes, any advancement in improving the quality of life for people with diabetes has to be welcomed!! Especially when it comes to the tedious and dreaded task of monitoring blood sugar levels!
EyeSense AG, the company who were involved in the study, showed that through use of its highly proprietary photometric sensor technology, which puts an ultra thin Optical Fiber Sensor, used as a Continuous Glucose Monitoring (CGM), placed transdermally under the skin of the abdomen or upper arm, for a period of two weeks, that they were able to lower the costs of glucose monitoring by at least 50% compared to the market leader.
In traditional Continuous Glucose Monitors, frequent changing of the sensors, led to them being a significant higher cost to use, therefore, were not used. Also the study showed, that blood sugar levels, were very closely matched to the traditional blood sugar monitoring results. The company are hoping to bring the system to the market by 2014.
EyeSense AG will present the data at the upcoming Advanced Technologies and Treatments for Diabetes Meeting (ATTD) in Barcelona, Spain from the 8th to 11th February 2012